Alkem Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

23.91

23.91

23.91

23.91

23.91

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

12,297.92

10,530.70

9,325.94

8,719.75

7,601.84

Loan funds

Secured loans

371.24

957.23

1,125.89

2,245.52

1,339.16

Unsecured loans

-

-

-

-

-

Total

12,693.07

11,511.84

10,475.74

10,989.18

8,964.91

Uses of funds

Fixed assets

Gross block

2,913.70

2,994.46

2,745.15

2,672.09

2,366.72

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,322.36

1,212.22

920.06

790.02

608.36

Net block

1,591.34

1,782.24

1,825.09

1,882.07

1,758.36

Capital work-in-progress

76.50

90.78

228.75

232.45

323.26

Investments

4,406.78

2,828.98

3,005.55

2,528.61

2,152.38

Net current assets

Current assets, loans & advances

9,520.98

9,335.80

7,671.83

8,526.04

6,538.73

Less : current liabilities & provisions

2,902.53

2,525.96

2,255.48

2,179.99

1,807.82

Total net current assets

6,618.45

6,809.84

5,416.35

6,346.05

4,730.91

Miscellaneous expenses not written

-

-

-

-

-

Total

12,693.07

11,511.84

10,475.74

10,989.18

8,964.91

Notes:

Book value of unquoted investments

787.09

221.40

2,782.40

235.16

221.98

Market value of quoted investments

580.54

57.32

223.15

-

-

Contingent liabilities

1,071.66

124.49

314.71

359.22

376.65

Number of equity sharesoutstanding (Lacs)

1195.65

1195.65

1195.65

1195.65

1195.65